| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
|
Cancer Res
|
2005
|
2.24
|
|
2
|
Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
|
Cancer Res
|
2005
|
1.55
|
|
3
|
WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
|
Mol Cancer Ther
|
2009
|
1.34
|
|
4
|
Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.
|
Cancer Prev Res (Phila)
|
2008
|
1.34
|
|
5
|
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.
|
Mol Cancer
|
2010
|
1.29
|
|
6
|
Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth.
|
Int J Cancer
|
2010
|
1.12
|
|
7
|
Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer.
|
J Ultrasound Med
|
2008
|
1.07
|
|
8
|
Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy.
|
Mol Carcinog
|
2011
|
0.97
|
|
9
|
Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels.
|
Neoplasia
|
2011
|
0.90
|
|
10
|
Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
|
Cancer Prev Res (Phila)
|
2013
|
0.90
|
|
11
|
Continent lower urinary tract reconstruction in the cervical spinal cord injured population.
|
J Urol
|
2003
|
0.89
|
|
12
|
Treatment- and disease-related complications of prostate cancer.
|
Rev Urol
|
2006
|
0.84
|
|
13
|
Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.
|
Recent Results Cancer Res
|
2014
|
0.80
|